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Alzheimer's disease (AD) is the most common cause of 
dementia and is characterized by a progressive decline 
of memory and other cognitive functions [1]. Emerging 
evidence suggests that AD disproportionately affects 
women in both occurrence and severity [1]. The 
molecular mechanism accounting for sex-related 
differences in AD remains unknown. Sex differences in 
amyloid β (Aβ) deposition as well as synaptic dys-
function in AD patients have been reported [2]. 
Gamma-aminobutyric acid (GABA) is the major 
inhibitory neurotransmitter in the central nervous 
system. Compelling evidence indicates that a disrupted 
default neuronal network underlies impaired memory 
and that alterations of GABAergic circuits may 
contribute to AD by disrupting the overall network 
function [3]. Whether GABAergic dysfunction is more 
severely affected in women than men remains to be 
established.  
Our groups recently observed that progression of 
GABAergic dysfunction in an animal model of AD is 
clearly influenced by sex [4]. Using state-of-the-art 
high-resolution magic angle spinning NMR we 
systematically mapped the levels of GABA across 
several brain regions in male and female AD mice. 
Divergent changes in hippocampal and cortical GABA 
concentrations were observed, which were gender-
specific. The GABA concentration in prefrontal cortex 
was more significantly affected in male as compared to 
female AD mice. In contrast, hippocampal GABA 
shows dynamic changes during Aβ pathology 
progression and its level was significantly elevated in 
old female as compared to old male AD mouse brain. 
To reveal the mechanism leading to high hippocampal 
GABA in female brain, we investigated the possible 
contribution of reactive astrocytes. Reactive astrocytosis 
is commonly observed in AD brain and much higher in 
female than male AD patients. While normal astrocytes 
do not contain much GABA, affected astrocytes around 
amyloid plaques become reactive and produce high 
amounts of GABA [5]. Till now, the role of reactive 
astrocytes has mainly been investigated in the context of 
inflammation or metabolic and structural support. Jo et 
al. [5] have recently reported the role of reactive 
astrocytes in producing GABA more aberrantly and 
abundantly in hippocampus, which was implicated in 
memory impairment in an AD mouse model. However, 
in those studies, the sex-specific  differences  in  GABA  








production have not been evaluated. In our study, we 
found a significantly higher number of reactive astro-
cytes in hippocampus of female than male AD mouse 
brain, which correlated with higher number of Aβ 
plaques, especially in stratum lacunosum moleculare 
and in dentate gyrus of hippocampus [4]. The analysis 
of the enzymes involved in GABA synthesis demons-
trated that glutamic acid decarboxylase (GAD) - which 
is essential for the production of GABA from glutamate 
in GABAergic neurons - displays low expression in 
hippocampus; especially in the areas surrounding Aβ 
plaques in both male and female AD mice. We then 
examined an alternative route of GABA production 
from putrescine via the monoamine oxidase-B (MAO-
B) route, which predominantly exists in reactive 
astrocytes. The expression of MAO-B was clearly 
elevated GFAP-positive reactive astrocytes in hippo-
campus of female mice and was co-localized with 
putrescine immunoreactivity. These results indicate that 
an abnormal increase in tonic GABA release from 
reactive astrocytes in the hippocampus may be directly 
responsible for the memory impairment in AD.  
The higher number of activated astrocytes and high 
amounts of hippocampal GABA in females may be 
associated with low estrogen levels in old females. 
Estrogen is known to act on hippocampal astrocytes of 
males and females via different mechanisms [1,6]. 
Additionally, estrogen-mediated neuroprotection in 
young female may partly be mediated by estrogen-
astrocyte interaction [6]. Estrogen is also known to 
down-regulate the expression of MAO-B [7]. However, 
a decline in the estrogen level in old females may 
hamper the neuroprotective effect of astrocytes, which 
may be intervened by high production of GABA via 
MAO-B route. Abnormally high GABA release via the 
Best1 channels can then activate neuronal GABA 
receptors, which can strongly inhibit synaptic release, 
leading to impairment of synaptic plasticity and 
memory function. Taken together these findings signify 
that astrocytes play a significant role in synaptic dys-
function and memory impairment in AD. A sexual 
dimorphism of hippocampal astrocytes to produce 
GABA exists in AD and it can be at the root of marked 
sex disparities observed in AD incidence, manifestation, 
and prognosis. 
The differential influence of sex on hippocampal 
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challenges from the perspective of treating memory 
decline. While the suppression of GABA production or 
release from reactive astrocytes would bring about 
desirable therapeutic effects on memory impairment in 
AD, different therapeutic strategies may be required for 
improving hippocampus-dependent memory functions 
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